Clinical Trials Logo

Filter by:
NCT ID: NCT04781842 Completed - Parkinson Disease Clinical Trials

Effect of a Boxing Program on People With Parkinson Disease

Start date: April 10, 2021
Phase: N/A
Study type: Interventional

This study is investigating the impact of a boxing training program on people with Parkinson Disease. The investigators were provided data for the intervention group retrospectively by the organizers of the boxing club to assess participants' benefit from participation. The outcome measures were selected to measure different aspects of functional mobility. Of particular interest is the impact of challenging whole-body activities designed for boxing and their impact on turning speed and gait. The second phase of the study will gather control group information from people with Parkinson Disease who have not participated in a boxing program to compare differences in pre-test and post-test data over a period of 12 weeks. The specific population and study design are currently pending global pandemic restrictions. Subject recruitment will involve people who have never had access to a program of this nature. An alternative population for recruitment may involve the same participants from the boxing club in a crossover study format since the boxing club has been suspended for over a year due to health and safety concerns during the pandemic. The control group of either situation would be instructed to carry on with their daily activities as usual without changing their physical activity. We hypothesize that the intervention group would show greater improvements in functional mobility compared to the control group.

NCT ID: NCT04781816 Completed - Clinical trials for Cutaneous Lupus Erythematosus

Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

CLEan
Start date: April 1, 2021
Phase: Phase 2
Study type: Interventional

Primary Objective: - Assess the efficacy of SAR443122 in cutaneous lupus erythematosus (CLE) Secondary Objectives: - Assess the effect of SAR443122 on the physician's global assessment of disease activity (PhysGA - disease activity) - Assess the effect of SAR443122 on CLE induced itch and overall pain - Assess the effect of SAR443122 on the proportion of disease activity responders compared to placebo - Assess the effect of SAR443122 on the CLASI components score - Assess the effect of SAR443122 on the Investigator's global assessment for CLE (IGA-CLE) - Assess oral cavities for patients with oral lesions - Assess the disease specific quality of life (QoL) - Assess the safety and tolerability of SAR443122 in patients with CLE - Assess the pharmacokinetics (PK) exposure of SAR443122 in patients with CLE

NCT ID: NCT04781127 Completed - Clinical trials for Treatment Resistant Depression

Home-administered tDCS for Treatment of Depression

Start date: February 10, 2021
Phase: Phase 1
Study type: Interventional

This study will determine the safety and efficacy of home administered tDCS in adults with unipolar depression. The device used to administer tDCS will be the Soterix Medical 1X1 mini-CT. 32 tDCS sessions of 30 minutes each will be delivered over 10 weeks.

NCT ID: NCT04781075 Completed - Pain, Postoperative Clinical Trials

Modified TAP (Transverse Abdominis Plane) Block in Colorectal Surgery

Start date: December 1, 2017
Phase: Phase 4
Study type: Interventional

Single Blind, Randomized Controlled study to see if TAP Block with Exparel provides better pain relief than TAP Block with bupivicaine. Differences in Pain Scale, Length of Stay, and Total Narcotic use in the hospital will be evaluated.

NCT ID: NCT04780984 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

Start date: November 1, 2020
Phase: Phase 2
Study type: Interventional

A Phase 2, Randomized, Partially-blinded, Parallel Group, Dose-ranging Study to Assess the Pharmacodynamics, Relative Bioavailability, and Safety of Three Doses of Tiotropium Bromide Inhalation Solution in Subjects with Chronic Obstructive Pulmonary Disease

NCT ID: NCT04780841 Completed - Hyperkalemia Clinical Trials

A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia

Redukx
Start date: January 11, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the ability of RDX013 to lower serum potassium in patients with chronic kidney disease with elevated serum potassium levels

NCT ID: NCT04780776 Completed - Clinical trials for Vitamin D Deficiency

Evaluating the Effect of Solius UV Light Source in Improving Vitamin D Status

Start date: February 23, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the safety and effectiveness of the Solius Photobiological System in improving serum levels of 25-hydroxyvitamin D in vitamin D deficient/ insufficient adults of various skin types. The invetigators will conduct an double-blinded randomized clinical trial in 100 adults to compare the changes in serum 25-hydroxyvitamin D levels between subjects who received and do not receive weekly exposures to Ultraviolet B Radiation (UVB) generated by the Solius Photobiological System for 16 weeks.

NCT ID: NCT04780698 Completed - Covid19 Clinical Trials

DCI COVID-19 Surveillance Project

Start date: February 12, 2021
Phase: N/A
Study type: Interventional

This is a prospective longitudinal census study conducted at a single center (DCI Inc., Henry Avenue, Philadelphia). The purpose of this study is to gain information about COVID-19 infection and antibody response in an in-center dialysis population. The investigators hypothesize that screening and surveillance for COVID-19 positive test (viral infection) and antibodies response to infection (potential immunity) in a dialysis center population within a high-prevalence region can provide foundational information to guide approaches toward prevention of COVID-19 related illness in a susceptible population. Participants will be given a questionnaire initially and monthly over the study period to find out whether they have had COVID-19 infection, hospitalization, or symptoms. A nasopharyngeal swab test for COVID-19 infection and a blood sample for COVID-19 antibody will be collected monthly for the study period.

NCT ID: NCT04780178 Completed - Anxiety Clinical Trials

Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With ADRD

(TACTICs)
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to test if Acceptance and Commitment Therapy (ACT), a behavioral intervention designed to increase psychological flexibility in the face of challenges, reduces anxiety associated psychological distress in dementia caregivers compared to the control group who will receive self-help and educational materials. This version of ACT is delivered over the phone in six primary sessions and one booster session.

NCT ID: NCT04779931 Completed - Clinical trials for Chronic Conditions, Multiple

Social Convoy Palliative Care (Convoy-Pal) Mobile Health for Older Adults

ConvoyPal
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to test the feasibility and usability of the Convoy-Pal mobile intervention among older adults. The study is a pilot waitlist control RCT with 40 patients and their convoys randomized to one of two arms: Convoy-Pal intervention or waitlist control. Feasibility will be assessed by recruitment, attrition, and data collection on measures of quality of life and social support. Usability will be captured by self-report usability scales and actual back end utilization data.